Equillium, Inc. (EQ)
1.27
-0.15
(-10.56%)
USD |
NASDAQ |
Oct 22, 16:00
1.26
-0.01
(-0.79%)
After-Hours: 20:00
Equillium Market Cap : 80.53M for Oct. 22, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 22, 2026 | 80.53M |
| October 21, 2026 | 90.04M |
| October 20, 2026 | 87.50M |
| October 19, 2026 | 78.63M |
| October 16, 2026 | 75.46M |
| October 15, 2026 | 83.70M |
| October 14, 2026 | 82.43M |
| October 13, 2026 | 83.70M |
| October 12, 2026 | 95.11M |
| October 09, 2026 | 89.41M |
| October 08, 2026 | 91.31M |
| October 07, 2026 | 88.14M |
| October 06, 2026 | 90.04M |
| October 05, 2026 | 91.94M |
| October 02, 2026 | 89.41M |
| October 01, 2026 | 97.65M |
| September 30, 2026 | 103.04M |
| September 29, 2026 | 102.72M |
| September 28, 2026 | 106.53M |
| September 25, 2026 | 105.89M |
| September 24, 2026 | 109.06M |
| September 23, 2026 | 110.96M |
| September 22, 2026 | 122.38M |
| September 21, 2026 | 120.16M |
| September 18, 2026 | 121.74M |
| Date | Value |
|---|---|
| September 17, 2026 | 119.84M |
| September 16, 2026 | 117.62M |
| September 15, 2026 | 129.99M |
| September 14, 2026 | 132.84M |
| September 11, 2026 | 133.79M |
| September 10, 2026 | 153.45M |
| September 09, 2026 | 162.32M |
| September 08, 2026 | 152.81M |
| September 04, 2026 | 140.13M |
| September 03, 2026 | 140.77M |
| September 02, 2026 | 142.67M |
| September 01, 2026 | 139.81M |
| August 31, 2026 | 143.94M |
| August 28, 2026 | 151.55M |
| August 27, 2026 | 155.35M |
| August 26, 2026 | 149.64M |
| August 25, 2026 | 138.23M |
| August 24, 2026 | 139.50M |
| August 21, 2026 | 146.47M |
| August 20, 2026 | 143.94M |
| August 19, 2026 | 147.74M |
| August 18, 2026 | 149.01M |
| August 17, 2026 | 157.25M |
| August 14, 2026 | 149.64M |
| August 13, 2026 | 127.45M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.496B |
| Alnylam Pharmaceuticals, Inc. | 30.40B |
| Anika Therapeutics, Inc. | 282.25M |
| Savara, Inc. | 932.51M |
| Vericel Corp. | 2.199B |
Market Cap Related Metrics
| Price to Book Value | 1.438 |
| Price | 1.27 |
| Earnings Yield | -15.99% |